Variant report

Variant	nsv886858
Chromosome Location	chr6:162612003-163023850
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:162857639-162857816	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:162671087-162671724	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:162794306-162794665	HepG2	liver:	n/a	n/a
4	ARID3A	chr6:162910482-162910786	HepG2	liver:	n/a	n/a
5	ATF1	chr6:162812647-162812847	K562	blood:	n/a	n/a
6	ATF1	chr6:162812215-162812339	K562	blood:	n/a	n/a
7	ATF1	chr6:162784797-162785113	K562	blood:	n/a	n/a
8	ATF1	chr6:162782228-162782581	K562	blood:	n/a	n/a
9	ATF3	chr6:162784742-162785052	K562	blood:	n/a	n/a
10	BACH1	chr6:162975725-162976098	K562	blood:	n/a	n/a
11	BHLHE40	chr6:162899266-162899534	GM12878	blood:	n/a	n/a
12	BRCA1	chr6:162871740-162871751	H1-hESC	embryonic stem cell:	n/a	n/a
13	BRCA1	chr6:162658617-162658742	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr6:162784775-162785143	K562	blood:	n/a	n/a
15	CBX3	chr6:162785538-162785848	K562	blood:	n/a	n/a
16	CCNT2	chr6:163001825-163002025	K562	blood:	n/a	n/a
17	CEBPB	chr6:162825981-162826255	HepG2	liver:	n/a	chr6:162826093-162826104
18	CEBPB	chr6:162868765-162868950	HepG2	liver:	n/a	chr6:162868884-162868895
19	CEBPB	chr6:162745722-162745922	HepG2	liver:	n/a	chr6:162745751-162745762
20	CEBPB	chr6:162943679-162943865	HepG2	liver:	n/a	n/a
21	CEBPB	chr6:162656289-162656489	A549	lung:	n/a	n/a
22	CEBPB	chr6:162857234-162857635	HepG2	liver:	n/a	chr6:162857420-162857431
23	CEBPB	chr6:162871496-162871684	HepG2	liver:	n/a	chr6:162871605-162871616
24	CEBPB	chr6:162675529-162675821	HepG2	liver:	n/a	chr6:162675652-162675661 chr6:162675652-162675661 chr6:162675652-162675663 chr6:162675650-162675661 chr6:162675652-162675661 chr6:162675650-162675663 chr6:162675652-162675661
25	CEBPB	chr6:162857299-162857541	HepG2	liver:	n/a	chr6:162857420-162857431
26	CEBPB	chr6:162910493-162910789	HepG2	liver:	n/a	n/a
27	CEBPB	chr6:162656180-162656471	HepG2	liver:	n/a	chr6:162656287-162656298 chr6:162656286-162656299
28	CEBPB	chr6:162636016-162636253	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr6:162766353-162766628	IMR90	lung:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
30	CEBPB	chr6:162652593-162652906	HepG2	liver:	n/a	chr6:162652751-162652762
31	CEBPB	chr6:162621122-162621414	ECC-1	luminal epithelium:	n/a	n/a
32	CEBPB	chr6:162910422-162910805	HepG2	liver:	n/a	n/a
33	CEBPB	chr6:162939387-162939585	HepG2	liver:	n/a	chr6:162939453-162939464
34	CEBPB	chr6:162910460-162910714	HepG2	liver:	n/a	n/a
35	CEBPB	chr6:162671584-162671889	IMR90	lung:	n/a	n/a
36	CEBPB	chr6:162766332-162766577	H1-hESC	embryonic stem cell:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
37	CEBPB	chr6:162871443-162871750	MCF-7	breast:	n/a	chr6:162871605-162871616
38	CEBPB	chr6:162766335-162766614	A549	lung:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
39	CEBPB	chr6:162784733-162785018	K562	blood:	n/a	n/a
40	CEBPB	chr6:162857280-162857594	HepG2	liver:	n/a	chr6:162857420-162857431
41	CEBPB	chr6:162766327-162766640	HepG2	liver:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
42	CEBPB	chr6:162634276-162634544	A549	lung:	n/a	chr6:162634418-162634429
43	CEBPB	chr6:162871405-162871712	H1-hESC	embryonic stem cell:	n/a	chr6:162871605-162871616
44	CEBPB	chr6:162871429-162871791	HepG2	liver:	n/a	chr6:162871605-162871616
45	CEBPB	chr6:162961979-162962215	HepG2	liver:	n/a	chr6:162962080-162962091
46	CEBPB	chr6:162861366-162861450	H1-hESC	embryonic stem cell:	n/a	chr6:162861390-162861403
47	CEBPB	chr6:162779025-162779284	HepG2	liver:	n/a	chr6:162779118-162779129
48	CEBPB	chr6:162671554-162671904	HepG2	liver:	n/a	n/a
49	CEBPB	chr6:162896813-162896974	HepG2	liver:	n/a	chr6:162896839-162896850
50	CEBPB	chr6:162670249-162670473	HepG2	liver:	n/a	chr6:162670378-162670389

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:162683961-162684011	HAEpiC	amniotic membrane:	n/a
2	chr6:162863505-162863555	NB4	blood:	n/a
3	chr6:162684441-162684491	HEEpiC	esophagus:	n/a
4	chr6:162865258-162865308	HCM	heart:	n/a
5	chr6:162683961-162684011	HAEpiC	amniotic membrane:	n/a
6	chr6:162863505-162863555	NB4	blood:	n/a
7	chr6:162684441-162684491	HEEpiC	esophagus:	n/a
8	chr6:162865258-162865308	HCM	heart:	n/a
9	chr6:162831837-162831887	HRE	kidney:	n/a
10	chr6:162865171-162865221	U87	brain:	n/a
11	chr6:162683961-162684011	HPAEpiC	pulmonary alveolar:	n/a
12	chr6:162684526-162684576	HEEpiC	esophagus:	n/a
13	chr6:162683857-162683907	Hepatocyte	liver:	n/a
14	chr6:162684526-162684576	PrEC	prostate:	n/a
15	chr6:162865171-162865221	GM06990	blood:	n/a
16	chr6:162865171-162865221	HEK293	kidney:	embryo
17	chr6:162831837-162831887	HUVEC	blood vessel:	n/a
18	chr6:162863505-162863555	T-47D	breast:	n/a
19	chr6:162683881-162683931	SK-N-MC	brain:	n/a
20	chr6:162683881-162683931	AG10803	skin:	n/a
21	chr6:162831837-162831887	AG09319	gingival:	n/a
22	chr6:162863505-162863555	AG04450	lung:	fetal
23	chr6:162683857-162683907	HMEC	breast:	n/a
24	chr6:162683961-162684011	AG09309	skin:	n/a
25	chr6:162683881-162683931	Hela-S3	cervix:	n/a
26	chr6:162865258-162865308	PANC-1	pancreas:	n/a
27	chr6:162684441-162684491	IMR90	lung:	fetal
28	chr6:162864586-162864636	CMK	blood:	n/a
29	chr6:162683961-162684011	HCF	heart:	n/a
30	chr6:162864586-162864636	SK-N-SH	brain:	n/a
31	chr6:162683961-162684011	AG04449	skin:	fetal
32	chr6:162865258-162865308	HPAEpiC	pulmonary alveolar:	n/a
33	chr6:162683881-162683931	MCF-7	breast:	n/a
34	chr6:162863505-162863555	SKMC	muscle:	n/a
35	chr6:162683857-162683907	LNCaP	prostate:	n/a
36	chr6:162684441-162684491	GM19239	blood:	n/a
37	chr6:162865258-162865308	HRCEpiC	kidney:	n/a
38	chr6:162683857-162683907	GM12891	blood:	n/a
39	chr6:162865258-162865308	HNPCEpiC	eye:	n/a
40	chr6:162683857-162683907	Jurkat	blood:	n/a
41	chr6:162964378-162964428	BE2_C	brain:	n/a
42	chr6:162864586-162864636	GM12891	blood:	n/a
43	chr6:162831837-162831887	ProgFib	skin:	n/a
44	chr6:162863505-162863555	Hela-S3	cervix:	n/a
45	chr6:162683857-162683907	GM06990	blood:	n/a
46	chr6:162864586-162864636	HPAEpiC	pulmonary alveolar:	n/a
47	chr6:162684441-162684491	GM12891	blood:	n/a
48	chr6:162683857-162683907	IMR90	lung:	fetal
49	chr6:162863505-162863555	BJ	skin:	n/a
50	chr6:162684526-162684576	PANC-1	pancreas:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
2	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
3	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
4	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
5	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
6	chr6:162960178..162962006-chr6:162962880..162965078,2	K562	blood:
7	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
8	chr6:163002877..163005708-chr6:163021910..163024946,3	K562	blood:
9	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
10	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
11	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
12	chr6:162960178..162962006-chr6:162962880..162965078,2	K562	blood:
13	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
14	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
15	chr6:163002877..163005708-chr6:163021910..163024946,3	K562	blood:
16	chr6:162863816..162864618-chr6:163271757..163272511,2	MCF-7	breast:
17	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
18	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
19	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
20	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
21	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
22	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
23	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
24	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
25	chr6:162863367..162864320-chr6:163157771..163158572,4	MCF-7	breast:
26	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
27	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
28	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
29	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
30	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:

Variant related genes	Relation type
KRT8P44	TF binding region
KRT8P44	CpG island

Extended variants
information (count: 17416 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:17416 , 50 per page) page: 1 2 3 4 5 6 7 ... 349

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9355988	chr6:162612003-162612004	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs531567486	chr6:162612024-162612025	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs531013227	chr6:162612044-162612045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs9365383	chr6:162612073-162612074	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs114312450	chr6:162612089-162612090	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs549257585	chr6:162612097-162612098	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs58841741	chr6:162612107-162612108	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs7764353	chr6:162612119-162612120	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs148520925	chr6:162612133-162612134	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs538648436	chr6:162612134-162612135	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs372649620	chr6:162612136-162612137	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs575629210	chr6:162612174-162612175	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs142789089	chr6:162612175-162612176	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs151066149	chr6:162612198-162612199	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs116325789	chr6:162612202-162612203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs540885646	chr6:162612222-162612223	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs560761939	chr6:162612223-162612224	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs187759714	chr6:162612232-162612233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs547271093	chr6:162612242-162612243	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs545463859	chr6:162612250-162612251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs192323768	chr6:162612259-162612260	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs531278401	chr6:162612260-162612261	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs184550128	chr6:162612284-162612285	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs189379112	chr6:162612290-162612291	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs377268558	chr6:162612365-162612366	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs181421887	chr6:162612406-162612407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs184953013	chr6:162612497-162612498	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs142385759	chr6:162612499-162612500	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs9347600	chr6:162612535-162612536	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs188572777	chr6:162612546-162612547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs569351045	chr6:162612599-162612600	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs34789342	chr6:162612644-162612645	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs145255839	chr6:162612689-162612690	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs555206305	chr6:162612694-162612695	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs575135668	chr6:162612726-162612727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs181610693	chr6:162612752-162612753	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs185937076	chr6:162612756-162612757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs577444624	chr6:162612764-162612765	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs115598323	chr6:162612771-162612772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs147605358	chr6:162612772-162612773	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs569595068	chr6:162612786-162612787	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs191196984	chr6:162612841-162612842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs55774230	chr6:162612849-162612850	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs182385325	chr6:162612851-162612852	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs527518872	chr6:162612867-162612868	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs547167744	chr6:162612878-162612879	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs73594259	chr6:162612887-162612888	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs533046295	chr6:162612891-162612892	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs77867697	chr6:162612909-162612910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs569112135	chr6:162612967-162612968	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Parkinson disease	21829596	CNVD
Schizophrenia	20967226	CNVD
Schizophrenia	21346763	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Autism	22495309	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	19805367	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:1323 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162605800-162624200	Weak transcription	Pancreas	Pancrea
2	chr6:162609600-162622000	Weak transcription	Left Ventricle	heart
3	chr6:162609600-162622400	Weak transcription	Psoas Muscle	Psoas
4	chr6:162610800-162612400	Enhancers	Fetal Heart	heart
5	chr6:162612000-162613000	Enhancers	Right Atrium	heart
6	chr6:162612400-162615800	Weak transcription	Fetal Heart	heart
7	chr6:162613000-162621600	Weak transcription	Spleen	Spleen
8	chr6:162613000-162622000	Weak transcription	Right Atrium	heart
9	chr6:162615800-162617200	Enhancers	Fetal Heart	heart
10	chr6:162616200-162616400	Weak transcription	Aorta	Aorta
11	chr6:162616200-162617200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr6:162617200-162621800	Weak transcription	Fetal Heart	heart
13	chr6:162618800-162619200	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr6:162619000-162619400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr6:162619000-162619400	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr6:162619200-162622000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
17	chr6:162619800-162620000	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr6:162620600-162620800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr6:162620800-162621400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
20	chr6:162620800-162623000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr6:162620800-162623000	Enhancers	Adipose Nuclei	Adipose
22	chr6:162621000-162622800	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr6:162621200-162622200	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr6:162621600-162622000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr6:162621600-162622400	Enhancers	Fetal Stomach	stomach
26	chr6:162621800-162622200	Enhancers	Fetal Kidney	kidney
27	chr6:162621800-162623000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr6:162621800-162623000	Enhancers	Fetal Heart	heart
29	chr6:162622000-162622200	Enhancers	Right Ventricle	heart
30	chr6:162622000-162622400	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr6:162622000-162622400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr6:162622000-162622400	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr6:162622000-162622400	Enhancers	Fetal Brain Male	brain
34	chr6:162622000-162622400	Enhancers	Left Ventricle	heart
35	chr6:162622000-162622400	Enhancers	Rectal Smooth Muscle	rectum
36	chr6:162622000-162622400	Enhancers	Right Atrium	heart
37	chr6:162622000-162622400	Active TSS	Stomach Smooth Muscle	stomach
38	chr6:162622000-162622600	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr6:162622000-162623000	Enhancers	Colon Smooth Muscle	Colon
40	chr6:162622200-162622800	Weak transcription	Skeletal Muscle Male	skeletal muscle
41	chr6:162622400-162622600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr6:162622400-162622800	Enhancers	Psoas Muscle	Psoas
43	chr6:162622400-162624200	Weak transcription	Cortex derived primary cultured neurospheres	brain
44	chr6:162622400-162624400	Weak transcription	Aorta	Aorta
45	chr6:162622400-162624400	Weak transcription	Fetal Stomach	stomach
46	chr6:162622400-162632000	Weak transcription	Left Ventricle	heart
47	chr6:162622400-162636000	Weak transcription	Right Atrium	heart
48	chr6:162622600-162623000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr6:162622800-162623000	Enhancers	Skeletal Muscle Male	skeletal muscle
50	chr6:162622800-162624200	Weak transcription	Psoas Muscle	Psoas

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links